正常月经周期中血清人附睾蛋白4水平的评估
本研究在罗德岛社区妇科诊所招募18-45岁月经规律的健康女性,每周期采集5次血和尿样,检测生殖激素和人附睾蛋白4(HE4)。74个入组周期中53名确认排卵并完成全部采集。血清HE4在整个月经周期相对稳定,仅排卵期小幅升高(中位数37.0 pM),尿HE4经肌酐校正后呈现与血清相同的分泌模式。
要点
- 血清HE4在育龄女性月经周期中相对稳定,可在任一天检测以评估卵巢恶性肿瘤风险。
- 排卵期HE4轻微升高,中位数为37.0 pM,但仍在健康女性参考范围内(<120 pM)。
- 尿HE4经肌酐校正后呈现与血清相同的分泌模式,用于临床实践的价值有待进一步研究。
核心结论
- 育龄女性血清HE4水平在月经周期中相对稳定,可在任一天检测以评估卵巢恶性肿瘤风险;排卵期轻微升高,但仍在健康参考范围内(<120 pM);尿HE4作为简便样本用于临床实践的价值有待进一步研究。
研究设计与样本
- 从罗德岛社区妇科诊所招募18-45岁、月经规律的健康女性,每个月经周期采集5次血和尿样本,检测生殖激素和HE4水平,数据经对数转换后采用线性回归分析。
- 74个入组周期中,53名女性确认排卵并完成全部5次样本采集。
主要发现
- 雌二醇、孕酮和黄体生成素呈现预期的月经周期模式。
- 血清HE4在整个月经周期相对稳定,仅排卵期小幅升高,中位数为37.0 pM。
- 尿HE4经肌酐校正后呈现与血清相同的分泌模式。
临床怎么用
- 血清HE4水平在育龄女性月经周期中相对稳定,可在任一天检测以评估卵巢恶性肿瘤风险。
- 排卵期HE4轻微升高,但结果仍在健康女性参考范围内(<120 pM)。
- 作者认为尿HE4作为简便样本用于临床实践的价值有待进一步研究。
局限性
- 尿HE4用于临床实践的价值有待进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human epididymis protein 4 is a serum biomarker to aid in differentiating benign and malignant disease in women with a pelvic mass. Interpretation of human epididymis protein 4 results relies on robust normative data. OBJECTIVE: The purpose of this study was to evaluate whether human epididymis protein 4 levels are variable in women during the normal menstrual cycle. STUDY DESIGN: Healthy women, 18-45 years old, with regular menstrual cycles were recruited from community gynecologic practices in Rhode Island. Women consented to enroll and to participate by the donation of blood and urine samples at 5 specific times over the course of each cycle. Levels of reproductive hormones and human epididymis protein 4 were determined. Data were analyzed with the use of linear regression after log transformation. RESULTS: Among 74 enrolled cycles, 53 women had confirmed ovulation during the menstrual cycle and completed all 5 sample collections. Levels of estradiol, progesterone, and luteinizing hormone displayed the expected menstrual cycle patterns. Levels of human epididymis protein 4 in serum were relatively stable across the menstrual cycle, except for a small ovulatory (median, 37.0 pM) increase. Levels of human epididymis protein 4 in urine, after correction for creatinine, displayed the same pattern of secretion observed in serum. CONCLUSION: Serum human epididymis protein 4 levels are relatively stable across the menstrual cycle of reproductive-aged women and can be determined on any day to evaluate risk of ovarian malignancy. A slight increase is expected at ovulation; but even with this higher human epididymis protein 4 level, results are well within the healthy reference range for women (<120 pM). Levels of human epididymis protein 4 in urine warrant further investigation for use in clinical practice as a simple and convenient sample.
引用
- Moore RG, Plante B, Hartnett E, et al. Assessment of serum HE4 levels throughout the normal menstrual cycle. Am J Obstet Gynecol. 2017. PMID: 28237871. doi:10.1016/j.ajog.2017.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。